folding of glutathione s-transferase Schematic representation the structure of a Glutathione S-transferase: A keystone in

Daratumumab is administered by IV infusion in combination with Pd at 16 mg/kg QW for 8 weeks, Q2W in weeks 924, and Q4W from week 25, and in combination with Kd at 8 mg/kg on days 1 and 2 in week 1, followed by 16 mg/kg QW in weeks 28, Q2W in weeks 924, and Q4W from week 25 [13, 15]

Our model also provides crucial insights for the design or optimization of artificial glutaredoxins, transition-state inhibitors and glutaredoxin-coupled redox sensors

This review explores the potential of MB in medical research and clinical applications, focusing on its diagnostic and therapeutic prospects

Fallon JK et al

Cederberg and Eriksson [216] suggested that catalase may play a protective role against diabetic embryopathy in rats, while ROS are implicated as mediators of this teratogenic process